New-Generation Injector Platform

Next-Generation Auto-Injector Platform Altaviz Unveils Gas-Powered Automatic Injector Platform for High-Viscosity and High-Volume Biologics Drug Delivery. Medical device and drug delivery platform designer, developer and manufacturer Altaviz announced the launch of AltaVISC, a new automatic injector platform designed for next-generation treatments. The advent of the AltaVISC Automatic Injector Platform opens a world of new possibilities for delivering high-viscosity, high-volume biologics with extraordinary simplicity and comfortable patient experience. While a significant portion of the industry still uses springs as a power source, AltaVISC offers a revolutionary approach: compressed gas cylinders called Pico-Cylinders. The AltaVISC Automatic Injector Platform leverages these Pico-Cylinders, developed by affiliate company Picocyl, with great impact, enabling the delivery of both high-volume and high-viscosity treatments while providing pulse-free delivery for an enhanced patient experience, expanding adjustability through gas pressure, and creating an environmentally conscious and sustainable impact. "To put it briefly, the AltaVISC Platform is better than everything else currently on the market," said Altaviz Co-CEO Jack Auld, continuing: "A practical, patient-centric solution for delivering next-generation treatments has not only been difficult until now, it simply did not exist. The Altaviz team is incredibly proud of AltaVISC and the difference this solution will make to patients, manufacturers, pharmaceutical companies, and the environment." AltaVISC also provides unique flexibility in product development and manufacturing processes. AltaVISC can be configured to deliver any drug formulation, including high-viscosity biologics and shear-sensitive molecules, offers a wide pressure range without form factor changes, and can provide controls over both human and environmental factors such as temperature and gas composition. Auld stated, "In developing this platform, we were extremely focused on creating a technology that leaves the current state of technology behind. As pharmaceutical companies move toward large-molecule, protein-based treatments and bring larger-volume treatments from the clinic to the home, we knew we needed to create a platform that combines the capacity to deliver the most challenging applications with the ease of reverting to any application. Ultimately, patients will benefit because the most cutting-edge treatments can now be self-administered in the most patient-friendly way possible. We want to improve their lives." AltaVISC holds a prominent place in the October 2023 issue of On Drug Delivery Magazine. In the article titled "Gas-Powered Automatic Injector Platform Enables Biologic Drug Delivery," the following advantages were highlighted compared to older spring-powered auto-injectors: • Enhanced capacity provided by Pico-Cylinders to deliver high viscosities, smaller needles, and large dose volumes. • Pulse-free delivery thanks to the AltaVISC gas-drive system. • Environmental sustainability through the use of atmospheric gases and reduced material requirements. AltaVISC can be truly characterized as a revolutionary technology for the next wave of revolutionary biologic therapeutics.   Source